Literature DB >> 24041350

Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer.

Yin Ting Cheung1, Si Rong Lim, Maung Shwe, Yee Pin Tan, Alexandre Chan.   

Abstract

OBJECTIVE: This study was designed to examine the psychometric properties and measurement equivalence of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Cognitive Function (Version 3) (FACT-Cog) in multiethnic Asian patients with breast cancer.
METHODS: This prospective study involved patients with breast cancer from the National Cancer Centre Singapore. The concurrent validity of the FACT-Cog was assessed according to its strength of correlation with the validated European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 cognitive functioning scale, and its association with fatigue, global health status, and anxiety. The known-group validity was assessed on the basis of receipt of chemotherapy. Factor analysis was conducted to ascertain the one-factor structure of each cognitive domain. The reliability was evaluated by using Cronbach's alpha and intraclass correlation coefficient within the cognitive domains. Multiple regression analyses were performed to compare the total scores between the two language versions, adjusting for covariates.
RESULTS: A total of 185 English-speaking and 143 Chinese-speaking patients were recruited. Both the English and Chinese FACT-Cog total scores correlated strongly with the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 cognitive functioning scale scores (r = 0.725 and 0.646), whereas correlations with fatigue, anxiety, and global health status were weak to moderate (|r| = 0.376-0.589). Regarding the known-group validity, more severe perceived cognitive disturbance was observed among patients receiving chemotherapy than among those who were not for both versions (P = .010 and .008, respectively). Internal consistencies within the cognitive domains were high (Cronbach's α 0.707-0.929), and test-retest reliability was satisfactory for both versions (intraclass correlation coefficient 0.762 and 0.697). The measurement equivalence between the English and Chinese versions was established for all domains except the multitasking domain.
CONCLUSION: The English and Chinese versions of the FACT-Cog are valid, reliable, and equivalent for clinical and research use.
Copyright © 2013, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

Entities:  

Keywords:  FACT-Cog; breast cancer; chemobrain; chemofog; chemotherapy; cognitive function; psychooncology; quality of life; validation

Mesh:

Substances:

Year:  2013        PMID: 24041350     DOI: 10.1016/j.jval.2013.06.017

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  26 in total

1.  The psychometric properties of the Korean version of the functional assessment of cancer therapy-cognitive (FACT-Cog) in Korean patients with breast cancer.

Authors:  Jin-Hee Park; Sun Hyoung Bae; Yong Sik Jung; Young-Mi Jung
Journal:  Support Care Cancer       Date:  2015-02-11       Impact factor: 3.603

2.  Drum-Assisted Recovery Therapy for Native Americans (DARTNA): results from a pretest and focus groups.

Authors:  Daniel L Dickerson; Kamilla L Venner; Bonnie Duran; Jeffrey J Annon; Benjamin Hale; George Funmaker
Journal:  Am Indian Alsk Native Ment Health Res       Date:  2014

3.  Psychometric properties and measurement equivalence of the English and Chinese versions of the Beck Anxiety Inventory in patients with breast cancer.

Authors:  Yu Ke; Terence Ng; Hui Ling Yeo; Maung Shwe; Yan Xiang Gan; Alexandre Chan
Journal:  Support Care Cancer       Date:  2016-10-22       Impact factor: 3.603

4.  Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.

Authors:  Chelsea Nicol; Tamara Ownsworth; Lee Cubis; William Nguyen; Matthew Foote; Mark B Pinkham
Journal:  J Cancer Surviv       Date:  2019-07-17       Impact factor: 4.442

5.  Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment.

Authors:  Victoria J Bray; Haryana M Dhillon; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2018-05-04       Impact factor: 4.442

6.  Mental Health, Physical Health, and Cultural Characteristics Among American Indians/Alaska Natives Seeking Substance Use Treatment in an Urban Setting: A Descriptive Study.

Authors:  Daniel L Dickerson; Elizabeth J D'Amico; David J Klein; Carrie L Johnson; Benjamin Hale; Feifei Ye
Journal:  Community Ment Health J       Date:  2020-07-27

7.  Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.

Authors:  Terence Ng; Ying Yun Lee; Jung-Woo Chae; Angie Hui Ling Yeo; Maung Shwe; Yan Xiang Gan; Raymond C H Ng; Pat Pak Yan Chu; Chiea Chuen Khor; Han Kiat Ho; Alexandre Chan
Journal:  BMC Cancer       Date:  2017-12-19       Impact factor: 4.430

8.  Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.

Authors:  Alexandre Chan; Claire Lew; Xiao Jun Wang; Terence Ng; Jung-Woo Chae; Hui Ling Yeo; Maung Shwe; Yan Xiang Gan
Journal:  Health Qual Life Outcomes       Date:  2018-01-19       Impact factor: 3.186

9.  Effect of Baduanjin exercise intervention on cognitive function and quality of life in women with breast cancer receiving chemotherapy: study protocol of a randomized controlled trial.

Authors:  Xiao-Lin Wei; Ru-Zhen Yuan; Yong-Mei Jin; Shu Li; Ming-Yue Wang; Jie-Ting Jiang; Cai-Qin Wu; Kun-Peng Li
Journal:  Trials       Date:  2021-06-19       Impact factor: 2.279

10.  Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.

Authors:  Terence Ng; Shu Mei Teo; Hui Ling Yeo; Maung Shwe; Yan Xiang Gan; Yin Ting Cheung; Koon Mian Foo; Mooi Tai Cham; Jung Ah Lee; Yee Pin Tan; Gilbert Fan; Wei Sean Yong; Madhukumar Preetha; Wei-Jen Kiley Loh; Si-Lin Koo; Amit Jain; Guek Eng Lee; Mabel Wong; Rebecca Dent; Yoon Sim Yap; Raymond Ng; Chiea Chuen Khor; Han Kiat Ho; Alexandre Chan
Journal:  Neuro Oncol       Date:  2015-08-19       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.